Insider Selling: ReposiTrak (NYSE:TRAK) CEO Sells 7,500 Shares of Stock

Key Points

• Randall Fields, CEO of ReposiTrak, sold 7,500 shares of the company's stock for a total of $116,025, resulting in a 17.65% decrease in his ownership.
• ReposiTrak's stock price has seen a decrease, trading at $15.05 with a market cap of $275.11 million and a P/E ratio of 43.00.
• Analysts have updated their ratings, with Weiss Ratings maintaining a "hold" rating while Wall Street Zen downgraded the rating from "buy" to "hold."

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 7,500 shares of the firm's stock in a transaction that occurred on Monday, October 20th. The stock was sold at an average price of $15.47, for a total transaction of $116,025.00. Following the sale, the chief executive officer owned 35,000 shares of the company's stock, valued at approximately $541,450. This represents a 17.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

ReposiTrak Stock Performance

Shares of TRAK stock traded down $0.16 during trading on Tuesday, hitting $15.05. 45,050 shares of the company were exchanged, compared to its average volume of 53,382. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.09 and a quick ratio of 6.09. The company has a market capitalization of $275.11 million, a price-to-earnings ratio of 43.00 and a beta of 0.44. The business's 50-day moving average is $16.18. ReposiTrak Inc. has a twelve month low of $13.86 and a twelve month high of $25.01.

ReposiTrak (NYSE:TRAK - Get Free Report) last posted its quarterly earnings results on Monday, September 29th. The company reported $0.09 EPS for the quarter. The business had revenue of $5.76 million during the quarter. ReposiTrak had a net margin of 30.55% and a return on equity of 14.25%.

Hedge Funds Weigh In On ReposiTrak

A number of institutional investors and hedge funds have recently bought and sold shares of TRAK. Ellsworth Advisors LLC increased its position in ReposiTrak by 10.6% during the first quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company's stock worth $634,000 after acquiring an additional 2,997 shares during the period. R Squared Ltd acquired a new stake in ReposiTrak during the second quarter worth $235,000. Ingalls & Snyder LLC boosted its stake in shares of ReposiTrak by 1.3% in the 2nd quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company's stock valued at $3,905,000 after purchasing an additional 2,554 shares in the last quarter. Los Angeles Capital Management LLC acquired a new stake in shares of ReposiTrak in the 2nd quarter valued at $818,000. Finally, Prescott Group Capital Management L.L.C. boosted its stake in shares of ReposiTrak by 47.2% in the 2nd quarter. Prescott Group Capital Management L.L.C. now owns 26,284 shares of the company's stock valued at $516,000 after purchasing an additional 8,428 shares in the last quarter. Institutional investors own 27.35% of the company's stock.

Analysts Set New Price Targets

TRAK has been the subject of a number of analyst reports. Weiss Ratings reiterated a "hold (c+)" rating on shares of ReposiTrak in a research note on Wednesday, October 8th. Wall Street Zen cut shares of ReposiTrak from a "buy" rating to a "hold" rating in a research note on Friday, October 3rd. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has an average rating of "Hold".

ReposiTrak Company Profile

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.